Developer docs
API playgroundTry for free, no card

Search company profiles

Cell Microsystems

Full company profile

uuid0000him

Namestring
Cell Microsystems
Legal namestring
Cell Microsystems, Inc.
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Cell Microsystems, Inc. is a Durham, North Carolina-based biotechnology company (incorporated in Delaware; founded 2010) that develops, manufactures, and markets instruments and consumables for single-cell biology, 2D/3D cell culture, shear flow analysis, automated electrophysiology, and cell counting. Its portfolio includes the CellRaft AIR System (single-cell isolation and clone generation using proprietary microscale polystyrene arrays and a fluidics-free glass transfer wand), BioFlux Systems (microfluidic shear flow with 0-200 dyn/cm² control), IonFlux Mercury (automated patch clamp with 16-256 parallel channels), CERO 3D (low-shear bioreactor for organoids/spheroids), CASY Cell Counter & Analyzer (Electronic Current Exclusion technology, GMP/GLP compliant with optional 21 CFR Part 11 module), and TIGR Tissue Grinder. The 2023 acquisition of Fluxion Biosciences added IsoFlux and expanded the BioFlux and IonFlux footprints. Underlying technology integrates proprietary hardware, single-use arrays/plates, and software (CellRaft Cytometry) with AI-assisted image-based verification of monoclonality and phenotypic selection.

The company monetizes through three streams: capital equipment (instruments sold via direct enterprise field sales with quote-based pricing), recurring consumables (CellRaft Arrays, BioFlux Plates, CERO and CASY consumables sold through a public e-commerce storefront with unit pricing from ~$200 to ~$2,750), and contract lab services (cell line development, 3D organoid generation, shear flow assays, and whole-cell patch clamp). GTM combines direct enterprise sales to academic and biopharma buyers (Request Quote/Demo CTAs) with self-serve e-commerce for consumables and lab services as an outsourced-evaluation pathway. Customer base spans academic institutions (UNC Chapel Hill, Duke, Harvard, Stanford, Johns Hopkins, Columbia, Max Planck, Carnegie Mellon, Penn, Albert Einstein, Washington University, Georgia State) and biopharmaceutical firms (Pfizer, Sanofi, Kite Pharma, Colossal Biosciences, an undisclosed Top 10 Global Biopharma).

Cell Microsystems has raised approximately $30 million across disclosed rounds since inception, including ~$12.7 million in November 2021 and ~$6.5 million in August 2023 (led by Telegraph Hill Partners per the funding ledger), with NIH and SBIR non-dilutive funding earlier. Headcount is reported at 11-50 employees, suggesting an established but still scale-stage private company that is reinvesting to broaden its product surface, grow international distribution (via the February 2024 OMNI Life Science alliance for 3D cell culture in North America), and integrate the Fluxion acquisition.

Short descriptiontext

Cell Microsystems is a Durham, NC-based private biotechnology company that develops and sells instruments, consumables, and lab services for single-cell isolation, 3D cell culture, shear flow analysis, automated patch clamp, and cell counting, serving academic research institutions and biopharmaceutical companies worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
single-cell isolation, automated patch clamp, 3D cell culture, shear flow analysis, cell biology instruments
Industry3 codes
PRIMARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAGAIAC
General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens)
SECONDARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • Laboratory Apparatus & Furniture3821
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Cell Biology Research Instruments
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Scientific Instruments
TypeHardware Sales
Description

Sale of capital equipment instruments including CellRaft AIR System, IonFlux Mercury, BioFlux Systems, CERO 3D, CASY Cell Counter, and TIGR Tissue Grinder. Instruments represent high-value capital purchases with typical enterprise sales cycles involving demos and quotes.

cellmicrosystems.com
2Consumables
TypeSubscription Recurring
Description

Recurring revenue from consumable products including CellRaft Arrays, BioFlux Plates, CERO Consumables (tubes, plates, solutions), and CASY Consumables (cups, ton, clean, blue solutions). Consumables are repurchased with each experiment or on regular intervals.

cellmicrosystems.com
3Lab Services
TypeProfessional Services
Description

Contract research services including cell line development, antibody services, 3D organoid generation and screening, shear flow experiments, and whole-cell patch clamp testing. Services provide project-based revenue and help drive instrument adoption.

cellmicrosystems.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details7 tiers
1BioFlux 1000HT 24-well Plates
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,750.00 per plate

cellmicrosystems.com
2BioFlux 1000HT 48-well Plates
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Low Shear: $2,000.00; High Shear: $1,750.00 per plate

cellmicrosystems.com
3BioFlux 200+ Plates
ModelUnit PricingBilling cadencePay-as-you-go
Notes

24-well: $1,750.00; 48-well Low Shear: $2,000.00; 48-well High Shear: $1,750.00 per plate

cellmicrosystems.com
4CellRaft Arrays
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Quad Reservoir: $582.62 - $2,621.77; Array Single Reservoir: $349.57 - $2,621.77 (price varies by configuration)

cellmicrosystems.com
5CERO Consumables
ModelUnit PricingBilling cadencePay-as-you-go
Notes

CEROTubes (48 units): $1,800.00; CEROsolution1 (4x10ml): $450.00; 96well CEROplate (24 plates): $1,300.00; 384well CEROplate (24 plates): $2,750.00

cellmicrosystems.com
6CASY Consumables
ModelUnit PricingBilling cadencePay-as-you-go
Notes

CASY cups 1box (1,800 cups): $525.00; CASY ton 1box (10-liter): $200.00; CASY clean 1x 500ml: $200.00; CASY blue 1x 30ml: $200.00

cellmicrosystems.com
7Instrument Systems (Quote-based)
ModelOtherBilling cadenceMulti-year contract
Notes

CellRaft AIR System, IonFlux Mercury, BioFlux Systems, CERO 3D, TIGR - pricing not publicly disclosed; requires Request Quote or Demo

cellmicrosystems.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1IonFlux Mercury
Description

Automated patch clamp system for ion channel research and drug discovery

cellmicrosystems.com
+5 more records
Core offering1 text field

Cell Microsystems develops, manufactures, and markets integrated instrument platforms and consumables for cell biology research, including the CellRaft AIR System for single-cell isolation and clone generation, BioFlux shear flow systems, IonFlux Mercury automated patch clamp systems, CERO 3D incubators and bioreactors, the CASY cell counter and analyzer, and the TIGR tissue grinder. The company also sells proprietary consumables (CellRaft Arrays, BioFlux Plates, CERO and CASY consumables), optimized mCells ion channel cell lines, and contract research lab services supporting cell line development, organoid generation, and electrophysiology studies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 10-50X increase in viable monoclonal colonies compared to limiting dilution
+5 more records
Product overview1 text field

Cell Microsystems offers a platform of cell engineering, culture, and analysis instruments designed for research and drug discovery applications. The core product lineup includes the CellRaft AIR System (single cell isolation and clone generation), BioFlux Systems (shear flow for physiological conditions), IonFlux Mercury Systems (automated patch clamp electrophysiology), CERO 3D (3D cell culture and bioreactor), CASY Cell Counter & Analyzer, and TIGR Tissue Grinder. The company also provides associated consumables (CellRaft Arrays, BioFlux Plates, CERO/CASY Consumables), optimized cell lines (mCells), and contract research lab services. Following the 2023 acquisition of Fluxion Biosciences, the portfolio expanded to include IsoFlux systems. Products integrate across 2D/3D cell biology, gene editing, genomics, stem cell research, and ion channel analysis workflows.

Product and service16 records
1CellRaft AIR System
CategoryCore instrument - single cell isolation and clone generation
Description

Integrated platform for imaging, identifying, and isolating viable single cells, colonies, or organoids using proprietary CellRaft Arrays and CellRaft Cytometry software; maintains cells in shared-media flask-like conditions with image-verified monoclonality for cell line development, gene editing, stem cell, and organoid workflows.

2BioFlux Systems (BioFlux 200+ and BioFlux 1000HT)
CategoryCore instrument - shear flow analysis
Description

Microfluidic shear flow systems that introduce physiological shear stress (0-200 dyn/cm²) to cell biology and microbiology experiments, with dual microenvironments, pulsatile flow capability, and high-throughput imaging of up to 24 experiments per plate for emulating in vivo conditions.

3IonFlux Mercury Systems
CategoryCore instrument - automated patch clamp electrophysiology
Description

Automated patch clamp systems providing 16 to 256 parallel channel recordings for high-throughput electrophysiology, with fast liquid exchange, continuous solution flow, and temperature control up to 40°C; offers one of the lowest costs per data point in the industry for ion channel drug discovery.

4CERO 3D Incubator & Bioreactor
CategoryCore instrument - 3D cell culture and bioreactor
Description

3D cell culture technology for organoid, spheroid, stem cell, and tissue research, featuring low-shear bi-directional rotation with precise automated control of CO2, temperature, and pH for long-term culture, expansion, and differentiation.

5CASY Cell Counter & Analyzer
CategoryCore instrument - cell counting and analysis
Description

Cell counting and analysis instrument using Electronic Current Exclusion (ECE) and Pulse Field Analysis technology to provide precise cell counts and viability assessments without dyes or reagents; GMP/GLP compliant with optional 21 CFR Part 11 module for regulated environments.

6TIGR Tissue Grinder and Dissociator
CategoryCore instrument - tissue dissociation
Description

Semi-automated benchtop tissue dissociation system using gentle mechanical rotor-stator grinding to yield high-quality single cells rapidly and reproducibly; processes four individual samples in parallel and is 5-15x faster than enzymatic methods with high cell viability.

7IsoFlux System
CategoryCore instrument - acquired brand (cell-based assay)
Description

Automated cell-based assay tool acquired from Fluxion Biosciences, expanding Cell Microsystems' offerings for cellular analysis and circulating tumor cell research applications.

8CellRaft Arrays
CategoryConsumable - CellRaft arrays
Description

Microwell arrays (Quad Reservoir and Single Reservoir formats) containing thousands of CellRafts for spatial segregation, imaging, and isolation of single cells, monoclonal colonies, or 3D cultures when used with the CellRaft AIR System.

9BioFlux Plates (BioFlux 200+ and BioFlux 1000HT)
CategoryConsumable - shear flow plates
Description

Specialized microfluidic plates (BioFlux 200+ and BioFlux 1000HT) for shear flow experiments, available in 24-well and 48-well formats with low-shear, high-shear, and custom substrate configurations for use with BioFlux Systems.

10CERO Consumables (CEROTubes, CEROsolution1, CEROplates)
CategoryConsumable - 3D cell culture
Description

Consumables including CEROTubes (48 units), CEROsolution1 (4x10ml), 96well CEROplate (24 plates), and 384well CEROplate (24 plates) for use with the CERO 3D Incubator & Bioreactor.

11CASY Consumables (CASY ton, cups, clean, blue)
CategoryConsumable - cell counting reagents and supplies
Description

Consumables for the CASY Cell Counter & Analyzer including CASY ton (10-liter container), CASY cups (1,800 cups), CASY clean (500ml), and CASY blue (30ml) reagents.

12mCells (Ion Channel-Optimized Cell Lines)
CategoryReagent - optimized cell lines
Description

Ion channel-optimized cell lines expressed in HEK-293 cells for use with IonFlux Mercury automated patch clamp systems; available channels include GABA A variants (α1β2γ2L, α2β2γ2L, α3β2γ2L).

13Cell Line Development Services
CategoryLab services - cell line development
Description

Contract research services utilizing CellRaft technology to generate gene-edited cell lines from challenging or rare cell types with results in weeks, including image-based validation and phenotypic screening.

143D Organoid Generation and Screening Services
CategoryLab services - 3D cell culture and organoids
Description

Matrix-based or bioreactor-based 3D cell culture services for reproducible assays using CellRaft and CERO 3D technologies.

15Shear Flow Assay Services
CategoryLab services - shear flow assays
Description

Contract research services using BioFlux Shear Flow Systems for platelet adhesion and cell invasion assays under physiological conditions.

16Whole-Cell Patch Clamp Services
CategoryLab services - automated patch clamp
Description

IonFlux automated patch clamp laboratory services for high-throughput electrophysiology recordings, including use of validated mCells for ion channel testing.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-01
Description

In February 2024, US-based Cell Microsystems formed a strategic alliance with Germany-based OMNI Life Science to introduce three 3D cell culture products in North America. This partnership enables Cell Microsystems to expand distribution of its CERO 3D and related 3D cell culture technology through OMNI Life Science's established network in the North American market.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cytena's single-cell cloning systems (c.sight and Cellenc) directly compete with CellRaft AIR for clonal cell line development workflows in pharma and cell therapy. Both address image-based verification of monoclonality and are sold into the same biopharma and academic accounts.

TypeDirect peer
Description

Molecular Devices offers automated patch clamp platforms (e.g., PatchXpress, OpusXpress, and higher-throughput systems) that compete directly with IonFlux Mercury in ion channel screening and drug discovery workflows for biopharma.

TypeDirect peer
Description

Nanion's automated patch clamp and bilayer electrophysiology systems (Port-a-Patch, SyncroPatch, Patchliner) compete with IonFlux Mercury in cardiac safety, ion channel research, and drug discovery markets.

TypeBroad incumbent
Description

BD's FACSDiscover and cell sorter families are the incumbent alternative to CellRaft for single-cell isolation and cloning. BD offers broad flow cytometry, cell sorting, and reagent portfolios used by the same academic and biopharma customers.

TypeBroad incumbent
Description

10x Genomics' Chromium single-cell platforms target genomic and transcriptomic single-cell analysis rather than clonal isolation, but they compete for the same single-cell biology budget and customer relationships within academic and biopharma labs.

6Sony Biotechnology
TypeDirect peer
Description

Sony Biotechnology's cell sorters (e.g., MA900, SH800) compete with BD and represent an incumbent option for fluorescence-activated single-cell isolation, an alternative approach to CellRaft's image-based isolation in cell line development workflows.

TypeDirect peer
Description

Beckman Coulter's Vi-Cell cell viability analyzers compete directly with the CASY Cell Counter & Analyzer in research and GMP cell counting applications across pharma and academic labs.

TypeDirect peer
Description

Mimetas' OrganoPlate 3D cell culture platforms compete with the CERO 3D Incubator & Bioreactor for organoid, spheroid, and organ-on-chip drug screening applications in academic and biopharma research.

TypeDirect peer
Description

InSphero provides 3D InSight microtissue platforms and organoid services that compete with CERO 3D-based workflows for disease modeling and drug discovery, serving overlapping biopharma and academic customers.

TypeBroad incumbent
Description

Thermo Fisher's broad lab instruments and cell biology portfolio (cell culture, cell counting, imaging, and cell line development tools) overlaps with several Cell Microsystems product lines and serves the same academic, biopharma, and CRO customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers17 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cell Microsystems

Cell Biology Research Instrumentscellmicrosystems.com

Cell Microsystems is a Durham, NC-based private biotechnology company that develops and sells instruments, consumables, and lab services for single-cell isolation, 3D cell culture, shear flow analysis, automated patch clamp, and cell counting, serving academic research institutions and biopharmaceutical companies worldwide.

What Cell Microsystems does

Cell Microsystems, Inc. is a Durham, North Carolina-based biotechnology company (incorporated in Delaware; founded 2010) that develops, manufactures, and markets instruments and consumables for single-cell biology, 2D/3D cell culture, shear flow analysis, automated electrophysiology, and cell counting. Its portfolio includes the CellRaft AIR System (single-cell isolation and clone generation using proprietary microscale polystyrene arrays and a fluidics-free glass transfer wand), BioFlux Systems (microfluidic shear flow with 0-200 dyn/cm² control), IonFlux Mercury (automated patch clamp with 16-256 parallel channels), CERO 3D (low-shear bioreactor for organoids/spheroids), CASY Cell Counter & Analyzer (Electronic Current Exclusion technology, GMP/GLP compliant with optional 21 CFR Part 11 module), and TIGR Tissue Grinder. The 2023 acquisition of Fluxion Biosciences added IsoFlux and expanded the BioFlux and IonFlux footprints. Underlying technology integrates proprietary hardware, single-use arrays/plates, and software (CellRaft Cytometry) with AI-assisted image-based verification of monoclonality and phenotypic selection.

The company monetizes through three streams: capital equipment (instruments sold via direct enterprise field sales with quote-based pricing), recurring consumables (CellRaft Arrays, BioFlux Plates, CERO and CASY consumables sold through a public e-commerce storefront with unit pricing from ~$200 to ~$2,750), and contract lab services (cell line development, 3D organoid generation, shear flow assays, and whole-cell patch clamp). GTM combines direct enterprise sales to academic and biopharma buyers (Request Quote/Demo CTAs) with self-serve e-commerce for consumables and lab services as an outsourced-evaluation pathway. Customer base spans academic institutions (UNC Chapel Hill, Duke, Harvard, Stanford, Johns Hopkins, Columbia, Max Planck, Carnegie Mellon, Penn, Albert Einstein, Washington University, Georgia State) and biopharmaceutical firms (Pfizer, Sanofi, Kite Pharma, Colossal Biosciences, an undisclosed Top 10 Global Biopharma).

Cell Microsystems has raised approximately $30 million across disclosed rounds since inception, including ~$12.7 million in November 2021 and ~$6.5 million in August 2023 (led by Telegraph Hill Partners per the funding ledger), with NIH and SBIR non-dilutive funding earlier. Headcount is reported at 11-50 employees, suggesting an established but still scale-stage private company that is reinvesting to broaden its product surface, grow international distribution (via the February 2024 OMNI Life Science alliance for 3D cell culture in North America), and integrate the Fluxion acquisition.

Cell Microsystems firmographics

Firmographics
Name
Cell Microsystems
Legal name
Cell Microsystems, Inc.
Website
https://cellmicrosystems.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Cell Microsystems is a Durham, NC-based private biotechnology company that develops and sells instruments, consumables, and lab services for single-cell isolation, 3D cell culture, shear flow analysis, automated patch clamp, and cell counting, serving academic research institutions and biopharmaceutical companies worldwide.
Ownership category
akta.pro rank

Cell Microsystems industry classification

Industry
Product category
Cell Biology Research Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Laboratory Analytical Instruments (3826), Laboratory Apparatus & Furniture (3821), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAGAIAC
General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens)
SECONDARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments

Keywords

  • Single-cell isolation
  • Automated patch clamp
  • 3D cell culture
  • Shear flow analysis
  • Cell biology instruments

Where Cell Microsystems is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Cell Microsystems business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Scientific Instruments: Sale of capital equipment instruments including CellRaft AIR System, IonFlux Mercury, BioFlux Systems, CERO 3D, CASY Cell Counter, and TIGR Tissue Grinder. Instruments represent high-value capital purchases with typical enterprise sales cycles involving demos and quotes.
  2. Consumables: Recurring revenue from consumable products including CellRaft Arrays, BioFlux Plates, CERO Consumables (tubes, plates, solutions), and CASY Consumables (cups, ton, clean, blue solutions). Consumables are repurchased with each experiment or on regular intervals.
  3. Lab Services: Contract research services including cell line development, antibody services, 3D organoid generation and screening, shear flow experiments, and whole-cell patch clamp testing. Services provide project-based revenue and help drive instrument adoption.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goBioFlux 1000HT 24-well Plates
Unit PricingPay-as-you-goBioFlux 1000HT 48-well Plates
Unit PricingPay-as-you-goBioFlux 200+ Plates
Unit PricingPay-as-you-goCellRaft Arrays
Unit PricingPay-as-you-goCERO Consumables
Unit PricingPay-as-you-goCASY Consumables
OtherMulti-year contractInstrument Systems (Quote-based)

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Cell Microsystems product offering

Product offering

Core offering

Cell Microsystems develops, manufactures, and markets integrated instrument platforms and consumables for cell biology research, including the CellRaft AIR System for single-cell isolation and clone generation, BioFlux shear flow systems, IonFlux Mercury automated patch clamp systems, CERO 3D incubators and bioreactors, the CASY cell counter and analyzer, and the TIGR tissue grinder. The company also sells proprietary consumables (CellRaft Arrays, BioFlux Plates, CERO and CASY consumables), optimized mCells ion channel cell lines, and contract research lab services supporting cell line development, organoid generation, and electrophysiology studies.

Product overview

Cell Microsystems offers a platform of cell engineering, culture, and analysis instruments designed for research and drug discovery applications. The core product lineup includes the CellRaft AIR System (single cell isolation and clone generation), BioFlux Systems (shear flow for physiological conditions), IonFlux Mercury Systems (automated patch clamp electrophysiology), CERO 3D (3D cell culture and bioreactor), CASY Cell Counter & Analyzer, and TIGR Tissue Grinder. The company also provides associated consumables (CellRaft Arrays, BioFlux Plates, CERO/CASY Consumables), optimized cell lines (mCells), and contract research lab services. Following the 2023 acquisition of Fluxion Biosciences, the portfolio expanded to include IsoFlux systems. Products integrate across 2D/3D cell biology, gene editing, genomics, stem cell research, and ion channel analysis workflows.

Differentiator

Problem solved

Functional benefit

Brands

  • IonFlux Mercury: Automated patch clamp system for ion channel research and drug discovery
  • CellRaft AIR
  • BioFlux
  • CERO 3D
  • TIGR
  • CASY

Products and services

  • CellRaft AIR System Integrated platform for imaging, identifying, and isolating viable single cells, colonies, or organoids using proprietary CellRaft Arrays and CellRaft Cytometry software; maintains cells in shared-media flask-like conditions with image-verified monoclonality for cell line development, gene editing, stem cell, and organoid workflows.
  • BioFlux Systems (BioFlux 200+ and BioFlux 1000HT) Microfluidic shear flow systems that introduce physiological shear stress (0-200 dyn/cm²) to cell biology and microbiology experiments, with dual microenvironments, pulsatile flow capability, and high-throughput imaging of up to 24 experiments per plate for emulating in vivo conditions.
  • IonFlux Mercury Systems Automated patch clamp systems providing 16 to 256 parallel channel recordings for high-throughput electrophysiology, with fast liquid exchange, continuous solution flow, and temperature control up to 40°C; offers one of the lowest costs per data point in the industry for ion channel drug discovery.
  • CERO 3D Incubator & Bioreactor 3D cell culture technology for organoid, spheroid, stem cell, and tissue research, featuring low-shear bi-directional rotation with precise automated control of CO2, temperature, and pH for long-term culture, expansion, and differentiation.
  • CASY Cell Counter & Analyzer Cell counting and analysis instrument using Electronic Current Exclusion (ECE) and Pulse Field Analysis technology to provide precise cell counts and viability assessments without dyes or reagents; GMP/GLP compliant with optional 21 CFR Part 11 module for regulated environments.
  • TIGR Tissue Grinder and Dissociator Semi-automated benchtop tissue dissociation system using gentle mechanical rotor-stator grinding to yield high-quality single cells rapidly and reproducibly; processes four individual samples in parallel and is 5-15x faster than enzymatic methods with high cell viability.
  • IsoFlux System Automated cell-based assay tool acquired from Fluxion Biosciences, expanding Cell Microsystems' offerings for cellular analysis and circulating tumor cell research applications.
  • CellRaft Arrays Microwell arrays (Quad Reservoir and Single Reservoir formats) containing thousands of CellRafts for spatial segregation, imaging, and isolation of single cells, monoclonal colonies, or 3D cultures when used with the CellRaft AIR System.
  • BioFlux Plates (BioFlux 200+ and BioFlux 1000HT) Specialized microfluidic plates (BioFlux 200+ and BioFlux 1000HT) for shear flow experiments, available in 24-well and 48-well formats with low-shear, high-shear, and custom substrate configurations for use with BioFlux Systems.
  • CERO Consumables (CEROTubes, CEROsolution1, CEROplates) Consumables including CEROTubes (48 units), CEROsolution1 (4x10ml), 96well CEROplate (24 plates), and 384well CEROplate (24 plates) for use with the CERO 3D Incubator & Bioreactor.
  • CASY Consumables (CASY ton, cups, clean, blue) Consumables for the CASY Cell Counter & Analyzer including CASY ton (10-liter container), CASY cups (1,800 cups), CASY clean (500ml), and CASY blue (30ml) reagents.
  • mCells (Ion Channel-Optimized Cell Lines) Ion channel-optimized cell lines expressed in HEK-293 cells for use with IonFlux Mercury automated patch clamp systems; available channels include GABA A variants (α1β2γ2L, α2β2γ2L, α3β2γ2L).
  • Cell Line Development Services Contract research services utilizing CellRaft technology to generate gene-edited cell lines from challenging or rare cell types with results in weeks, including image-based validation and phenotypic screening.
  • 3D Organoid Generation and Screening Services Matrix-based or bioreactor-based 3D cell culture services for reproducible assays using CellRaft and CERO 3D technologies.
  • Shear Flow Assay Services Contract research services using BioFlux Shear Flow Systems for platelet adhesion and cell invasion assays under physiological conditions.
  • Whole-Cell Patch Clamp Services IonFlux automated patch clamp laboratory services for high-throughput electrophysiology recordings, including use of validated mCells for ion channel testing.

Quantifiable outcome

  • 10-50X increase in viable monoclonal colonies compared to limiting dilution
  • +5 more outcomes

Companies that use Cell Microsystems

Customer profile

Named customers17 records

Segments3 records

Ideal customer profiles2 records

Cell Microsystems technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Cell Microsystems partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • OMNI Life SciencecoreStrategic or Co-development Partner · 1 February 2024In February 2024, US-based Cell Microsystems formed a strategic alliance with Germany-based OMNI Life Science to introduce three 3D cell culture products in North America. This partnership enables Cell Microsystems to expand distribution of its CERO 3D and related 3D cell culture technology through OMNI Life Science's established network in the North American market.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Cell Microsystems competitors and assessment

Company assessment

Direct peers

  • Cytena (BICO Group): Cytena's single-cell cloning systems (c.sight and Cellenc) directly compete with CellRaft AIR for clonal cell line development workflows in pharma and cell therapy. Both address image-based verification of monoclonality and are sold into the same biopharma and academic accounts.
  • Molecular Devices (Danaher): Molecular Devices offers automated patch clamp platforms (e.g., PatchXpress, OpusXpress, and higher-throughput systems) that compete directly with IonFlux Mercury in ion channel screening and drug discovery workflows for biopharma.
  • Nanion Technologies: Nanion's automated patch clamp and bilayer electrophysiology systems (Port-a-Patch, SyncroPatch, Patchliner) compete with IonFlux Mercury in cardiac safety, ion channel research, and drug discovery markets.
  • Sony Biotechnology: Sony Biotechnology's cell sorters (e.g., MA900, SH800) compete with BD and represent an incumbent option for fluorescence-activated single-cell isolation, an alternative approach to CellRaft's image-based isolation in cell line development workflows.
  • Beckman Coulter Life Sciences (Danaher): Beckman Coulter's Vi-Cell cell viability analyzers compete directly with the CASY Cell Counter & Analyzer in research and GMP cell counting applications across pharma and academic labs.
  • Mimetas: Mimetas' OrganoPlate 3D cell culture platforms compete with the CERO 3D Incubator & Bioreactor for organoid, spheroid, and organ-on-chip drug screening applications in academic and biopharma research.
  • InSphero: InSphero provides 3D InSight microtissue platforms and organoid services that compete with CERO 3D-based workflows for disease modeling and drug discovery, serving overlapping biopharma and academic customers.

Broad incumbents

  • BD Biosciences (Becton Dickinson): BD's FACSDiscover and cell sorter families are the incumbent alternative to CellRaft for single-cell isolation and cloning. BD offers broad flow cytometry, cell sorting, and reagent portfolios used by the same academic and biopharma customers.
  • 10x Genomics: 10x Genomics' Chromium single-cell platforms target genomic and transcriptomic single-cell analysis rather than clonal isolation, but they compete for the same single-cell biology budget and customer relationships within academic and biopharma labs.
  • Thermo Fisher Scientific: Thermo Fisher's broad lab instruments and cell biology portfolio (cell culture, cell counting, imaging, and cell line development tools) overlaps with several Cell Microsystems product lines and serves the same academic, biopharma, and CRO customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Cell Microsystems social profiles

Digital presence

Cell Microsystems compliance and trust

Trust signal

Compliance1 record

Cell Microsystems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cell Microsystems leadership team

Management profile

Number of profiles

Profiles5 records

Cell Microsystems subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Cell Microsystems funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cell Microsystems M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cell Microsystems

What does Cell Microsystems do?

Cell Microsystems develops, manufactures, and markets integrated instrument platforms and consumables for cell biology research, including the CellRaft AIR System for single-cell isolation and clone generation, BioFlux shear flow systems, IonFlux Mercury automated patch clamp systems, CERO 3D incubators and bioreactors, the CASY cell counter and analyzer, and the TIGR tissue grinder. The company also sells proprietary consumables (CellRaft Arrays, BioFlux Plates, CERO and CASY consumables), optimized mCells ion channel cell lines, and contract research lab services supporting cell line development, organoid generation, and electrophysiology studies.

Is Cell Microsystems a public or private company?

Cell Microsystems is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cell Microsystems founded?

Cell Microsystems was founded in 2020. It employs 11 to 50 people.

Where is Cell Microsystems based?

Cell Microsystems is headquartered in Durham, United States, in the North America region.

How does Cell Microsystems make money?

Three revenue lines are on record. Scientific Instruments are the primary driver. The others are consumables and lab Services.

Who are Cell Microsystems's main competitors?

Direct peers on record are Cytena (BICO Group), Molecular Devices (Danaher), Nanion Technologies, Sony Biotechnology, Beckman Coulter Life Sciences (Danaher), Mimetas and InSphero. Broad incumbents are BD Biosciences (Becton Dickinson), 10x Genomics and Thermo Fisher Scientific.

Does Cell Microsystems have an API?

No public API is recorded for Cell Microsystems.

What industry is Cell Microsystems in?

Cell Microsystems's product category is Cell Biology Research Instruments. Its primary akta.pro industry code is HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers), with a secondary code of HLAGAIAC, General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireCell Microsystems Launches Software Supporting 21 CFR Part 11 Compliance, Expanding CellRaft AIR to Regulated WorkflowsCell Microsystems launched new software for its CellRaft AIR system to support 21 CFR Part 11 compliance, adding secure electronic records, audit trails, and workflow controls. The software expands the platform from discovery and cell line development into regulated cell-based workflows for monoclonal, gene-edited, and cell therapy applications.openPR.comIn-Depth Examination of Segments, Industry Developments, and Key Players in the Organoids and Spheroids MarketThe Business Research Company released a market report on the organoids and spheroids sector, projecting the market to reach $3.44 billion by 2030 with a 19.7% CAGR, driven by demand for personalized medicine and 3D culture technology advances. In February 2024, US-based Cell Microsystems formed a strategic alliance with Germany-based OMNI Life Science to introduce three 3D cell culture products in North America. Austrian medical tech firm Biolitec AG launched new laser fiber and laser products in June 2023 targeting minimally invasive varicose vein treatment.openPR.comSegment Evaluation and Major Growth Areas in the Cell Counting MarketThe global cell counting market is projected to reach $17.83 billion by 2030, growing at a compound annual growth rate of 9.3%, driven by rising demand for cell-based therapies, precision diagnostics, and AI-driven laboratory analytics. In August 2023, US-based Cell Microsystems acquired Fluxion Biosciences, a biotechnology company specializing in microfluidic technology and cellular analysis, to expand its single-cell analysis and precision medicine offerings. Additionally, Becton Dickinson and Company launched the BD FACSDiscover S8 spectral cell sorter in May 2023, introducing spectral cell sorting technology that captures full-spectrum signals for enhanced cell analysis in drug discovery and genomics.PharmiWeb.comInnovations in Biomarker Detection Transform the Circulating Tumor Cells Market LandscapeThe global Circulating Tumor Cells market is experiencing robust growth driven by rising cancer prevalence, demand for non-invasive liquid biopsy technologies, and advancements in microfluidic platforms and AI-driven analysis. Recent corporate activity includes Bio-Rad Laboratories launching validated antibodies for CTC enumeration in March 2024, Cell Microsystems acquiring Fluxion Biosciences in August 2023, and Bio-Techne announcing its acquisition of Swiss company LunaPhore in June 2023 to expand tissue imaging capabilities. North America dominates the market due to advanced healthcare infrastructure, high research investments, and supportive regulatory frameworks, though challenges around high platform costs, lack of standardized protocols, and technical complexity in CTC isolation continue to limit broader adoption.BiotechniquesFrom the floor at Neuroscience 2024The article reports on presentations and product showcases by several biotechnology companies at the Neuroscience 2024 conference in Chicago. It highlights specific technologies from CelVivo, Zymo Research, Meteor Biotech, and Cell Microsystems designed to advance neuroscience research through cell culture, sequencing, and analysis tools. The content serves as a summary of industry partner activities rather than a report on a singular corporate event.News-MedicalCell Microsystems and OMNI Life Science Announce Strategic Partnership to Bring Innovative Cellular Analysis Solutions to North AmericaCell Microsystems and OMNI Life Science announced a strategic partnership to bring CERO, CASY, and TIGR products to the US and Canadian markets. The collaboration aims to advance cell biology research by providing state-of-the-art tools for 3D culture, cell counting, and tissue dissociation.WRAL TechWireDurham biotech startup acquires California company after raising $6.5MCell Microsystems acquired Oakland-based Fluxion Biosciences, a developer of automated patch clamp technology, to complement its CellRaft platform. The acquisition was supported by a $6.5 million Series B led by Telegraph Hill Partners, with the company planning to expand from 37 to 48 employees.SecSEC FORM DCell Microsystems, Inc. filed a Form D with the Securities and Exchange Commission to report an exempt offering of equity securities under Rule 506(b). The company disclosed a total offering amount of $13,000,668, with $6,500,000 already sold as of the filing date of August 28, 2023. This regulatory filing notifies authorities of the private placement details, including the jurisdiction of incorporation in Delaware.ThpartnersCell Microsystems Acquires Fluxion Biosciences to Broaden Cell Analysis Product and Services PortfolioCell Microsystems has acquired Fluxion Biosciences to expand its cell analysis product portfolio with automated patch clamp technology and cell-based assay tools. The transaction was supported by a concurrent Series B financing led by Telegraph Hill Partners, which provides growth capital for the combined entity's future advancements.